Which words do the narrowing?
Four words keep the approval to one use in one group. Each blocks a different wider reading. The ladder below drops one word at a time and shows what you'd wrongly be claiming.
-
Remove: acquired
Take the word out and the sentence reaches a presentation that was always present. The record's indication is an acquired one, a change from an earlier state, and dropping the word reports a reach the record does not have.
-
Remove: generalized
Take the word out and the sentence reaches a presentation tied to one situation or one partner. The record's indication is a generalized one, and the removed word was holding that line.
-
Remove: premenopausal
Take the word out and the sentence reaches every woman. The record's population is narrower than that, and premenopausal is part of what defines the one population the label covers.
-
Remove: women
Take the word out and the sentence reaches beyond that population entirely, men included. The label covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose, and dropping the word crosses the line the record draws.
Put back together, here's the sentence we stand by: An approval in the United States for acquired, generalized hypoactive sexual desire disorder in premenopausal women, and an approved label covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. Citation: https://pubmed.ncbi.nlm.nih.gov/31429064/.
What is the compound, according to the record?
The record calls it a synthetic peptide analogue of alpha-MSH, acting as an agonist at melanocortin receptors, including the MC3R and MC4R subtypes expressed primarily in the central nervous system. It uses both names, PT-141 and bremelanotide, for the one compound. That's a description, not an account of what happens to a person. Citation: https://pubmed.ncbi.nlm.nih.gov/12851303/.
What doesn't the approval cover?
The record doesn't extend the approval to men, to a postmenopausal group, to desire in general, to weight or to kidney function. An approved label covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. We also never place paragraphs so you'd connect a wider claim we didn't write. See where the record stops for men and what two re-analyses dispute.
Where did we read it?
In the supplier fact pack, read 2026-09-07, and two published records, read 2026-09-05. We never opened the label itself, so we don't name or link a regulator's document. Saying so is a finding too. Back to the scope table.
About the supplier we name
What is Peptara Labs, and what does it publish?
Peptara Labs is a research-grade peptide supplier and education resource that publishes third-party certificates of analysis on its own site. It lists sixteen research-grade products, including this one. We name it because its lot for this compound is the one we show.
Who tests the peptides Peptara Labs sells?
Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. We always keep that qualifier with the name. A quality system aligned to a standard is not the same as holding it.
Is Peptara Labs the source of an approved PT-141 product?
No. Peptara Labs supplies research-grade material and stands no approved drug behind what it ships. The approval that does exist covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. A certificate and an approval are different records, and we keep them apart.
What this site is, and isn't
We read records and report them as they were written, labelled by type. Supplier documents are reported in their own terms. Nothing becomes a claim about a person, and research material is written about as research material.
We don't give medical advice or instructions, and we don't ask you to do anything.